Atlas Trials

An Online-platform to Improve Patient-centered Care During the COVID-19 Pandemic: a GIMEMA Surveillance Program in Hematologic Malignancies

Clinical trial NCT04581187 · UNKNOWN

Trial details

NCT number
NCT04581187
Sponsor
Gruppo Italiano Malattie EMatologiche dell'Adulto
Status
UNKNOWN
Study type
OBSERVATIONAL
Hematologic Malignancies
Start date
2020-12-02
Primary completion
2022-12-01
Enrollment
400

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.